HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Consumer Solutions Worldwide (CSW), (Cayman) Limited

Volume:- -

Turnover:- -

Market Cap:- -

PE:- -

High:- -

Open:- -

Low:- -

Close:- -

52wk High:- -

52wk Low:- -

Shares:- -

HK Float Shares:- -

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

PS:- -

Loading ...

Overview Company News Filings

Wuxi Biologics (Cayman) Stock Advances 1.3% in Hong Kong

Wuxi Biologics (Cayman) Stock Sheds 3.2% in Hong Kong

Intercont (Cayman) Limited 2026 Strategic Plan Release – Anchoring the Core Shipping Business, Multi-Sector Synergy Opens New Growth Trajectories

Wuxi Biologics (Cayman) Stock Rallies 3.4% in Hong Kong

Macquarie Upgrades ZTO Express (Cayman) to Outperform From Neutral, Adjusts Price Target to $26.60 From $18.40

MT Newswires Live

Wuxi Biologics (Cayman) Stock Rises 1.5% in Hong Kong

Qinqin Foodstuffs Group (Cayman) Company Limited's (HKG:1583) most bullish insider is Top Key Executive Ching Lau Hui, and their holdings value went up by 18% last week

Simply Wall St.

Dingdong (Cayman) Ltd. Down Over 15%, on Pace for Largest Percent Decrease Since May 2024 -- Data Talk

WuXi Biologics Alliances Deepen Role In Complex Autoimmune And Fusion Drugs

Simply Wall St.

Phaos Technology Holdings (Cayman) Limited Provides Response to Unusual Market Action

Wuxi Biologics (Cayman) Stock Advances 2.6% in Hong Kong

Assessing WuXi Biologics (SEHK:2269) Valuation After New Autoimmune And Biologics Collaboration Wins

Simply Wall St.

Returns On Capital Are Showing Encouraging Signs At Luyuan Group Holding (Cayman) (HKG:2451)

Simply Wall St.

Wuxi Biologics (Cayman) Stock Slides 3.1% in Hong Kong

Wuxi Biologics (Cayman) Stock Sheds 2.4% in Hong Kong

Wuxi Biologics (Cayman) Stock Slides 2.8% in Hong Kong

A Look At ZTO Express (NYSE:ZTO) Valuation After Its 2026 Network Conference Growth Plans

Simply Wall St.

Capital Allocation Trends At Tenfu (Cayman) Holdings (HKG:6868) Aren't Ideal

Simply Wall St.

New UK MHRA Certifications and PatroLab Platform Might Change The Case For Investing In WuXi Biologics (Cayman) (SEHK:2269)

Simply Wall St.

ZTO Express Shifts To Quality Led Growth After Volume Leadership Run

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/91347/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"91347","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"91347\",,,,,undefined,":{"symbol":"91347","market":"HK","secType":"STK","nameCN":"Consumer Solutions Worldwide (CSW), (Cayman) Limited","latestPrice":0,"timestamp":1771920000000,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-24 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771983000000},"marketStatusCode":0,"adr":0,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1771896600000,1771905600000],[1771909200000,1771920000000]],"volumeRatio":0,"lotSize":0,"spreadScale":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"91347\",,,,,undefined,":{"symbol":"91347","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/91347\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"91347\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"91347\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"91347\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611210456","title":"Wuxi Biologics (Cayman) Stock Advances 1.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2611210456","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611210456?lang=en_us&edition=fundamental","pubTime":"2026-02-16 16:32","pubTimestamp":1771230720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rallied 1.3% to 40.50 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 26705.94.The stock's rise snapped a two-day losing streak.Wuxi Biologics  Inc. closed 8.0% below its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 7.1 million shares, compared to the 50-day average of 36.4 million shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0856984785.SGD","02269","LU0456827905.SGD","LU0327786744.USD","LU0359201612.USD","LU0417516738.SGD","LU0456846285.SGD","LU0320764599.SGD","LU1880383366.USD","BK1141","SG9999002463.SGD","LU0043850808.USD","LU0417516902.SGD","LU1242518931.SGD","IE00B0JY6N72.USD","LU1720050803.USD","SG9999002562.SGD","LU0979878070.USD","BK1521","LU0181495838.USD","LU0819121731.USD","LU0140636845.USD","LU0588546209.SGD","LU1688375341.USD","LU0516422440.USD","BK1576","LU0516423091.SGD","LU0348735423.USD","LU2039709279.SGD","LU0348825331.USD","LU0516422366.SGD","LU0708995583.HKD","LU0516422952.EUR","LU0823426308.USD","LU0572944931.SGD","LU0359202008.SGD","91347","LU1794554557.SGD","BK1589","LU0326950275.SGD","LU3063872942.SGD","LU0039217434.USD","BK1610","LU0052750758.USD","LU1242518857.USD","LU0823426480.USD","LU0051755006.USD","LU0516423174.USD","LU0307460666.USD"],"gpt_icon":0},{"id":"2611134800","title":"Wuxi Biologics (Cayman) Stock Sheds 3.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2611134800","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611134800?lang=en_us&edition=fundamental","pubTime":"2026-02-13 16:31","pubTimestamp":1770971460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slipped 3.2% to 40.00 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.7% to 26567.12.This was the stock's second consecutive day of losses.Wuxi Biologics  Inc. closed 9.1% below its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 38.1 million shares, compared to the 50-day average of 35.9 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0043850808.USD","LU0320764599.SGD","LU0456846285.SGD","LU1242518857.USD","LU0823426480.USD","LU0708995583.HKD","LU0326950275.SGD","LU0516423091.SGD","BK1576","LU0039217434.USD","LU0348735423.USD","LU0516422440.USD","LU0572944931.SGD","LU1794554557.SGD","02269","LU0516422366.SGD","LU0516422952.EUR","LU0327786744.USD","LU0348825331.USD","BK1141","LU0516423174.USD","BK1521","91347","BK1589","LU0417516738.SGD","LU0307460666.USD","LU0359201612.USD","LU0417516902.SGD","BK1610","LU0140636845.USD","LU1688375341.USD","IE00B0JY6N72.USD","LU0979878070.USD","LU1242518931.SGD","LU1720050803.USD","LU0823426308.USD","LU2039709279.SGD","LU0051755006.USD","LU0181495838.USD","LU0856984785.SGD","LU0819121731.USD","SG9999002562.SGD","LU0359202008.SGD","LU0456827905.SGD","LU1880383366.USD","LU3063872942.SGD","LU0588546209.SGD","SG9999002463.SGD","LU0052750758.USD"],"gpt_icon":0},{"id":"2610192785","title":"Intercont (Cayman) Limited 2026 Strategic Plan Release – Anchoring the Core Shipping Business, Multi-Sector Synergy Opens New Growth Trajectories","url":"https://stock-news.laohu8.com/highlight/detail?id=2610192785","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610192785?lang=en_us&edition=fundamental","pubTime":"2026-02-12 22:00","pubTimestamp":1770904800,"startTime":"0","endTime":"0","summary":"SINGAPORE, Feb.  12, 2026  (GLOBE NEWSWIRE) -- Recently, Intercont (Cayman) Limited (hereinafter referred to as \"Intercont\") released its 2026 strategic outlook and growth plan, positioning this year ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/12/3237267/0/en/Intercont-Cayman-Limited-2026-Strategic-Plan-Release-Anchoring-the-Core-Shipping-Business-Multi-Sector-Synergy-Opens-New-Growth-Trajectories.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4543","BK4588","91347","AI","BK4023","BK4587","BK4585","BK4528"],"gpt_icon":0},{"id":"2610847709","title":"Wuxi Biologics (Cayman) Stock Rallies 3.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2610847709","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610847709?lang=en_us&edition=fundamental","pubTime":"2026-02-11 16:31","pubTimestamp":1770798660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. advanced 3.4% to 41.40 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.3% to 27266.38.This was the stock's fifth consecutive day of gains.Wuxi Biologics  Inc. closed 2.8% below its 52-week high of HK$42.60, which the company reached Oct. 3.Trading volume totaled 34.5 million shares, compared to the 50-day average of 34.5 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU3063872942.SGD","LU1242518857.USD","LU0327786744.USD","LU2039709279.SGD","LU0417516902.SGD","LU0320764599.SGD","LU0051755006.USD","LU0572944931.SGD","LU1242518931.SGD","LU0516423174.USD","LU0856984785.SGD","SG9999002562.SGD","LU0039217434.USD","BK1521","LU0456846285.SGD","LU0359202008.SGD","LU1880383366.USD","LU0181495838.USD","LU0307460666.USD","LU0417516738.SGD","LU0516422952.EUR","LU0819121731.USD","LU0516422440.USD","LU0979878070.USD","IE00B0JY6N72.USD","LU1720050803.USD","LU0516422366.SGD","SG9999002463.SGD","BK1141","BK1576","LU0588546209.SGD","LU0326950275.SGD","91347","LU0052750758.USD","LU0516423091.SGD","LU0708995583.HKD","LU0823426308.USD","BK1589","LU0140636845.USD","LU0348735423.USD","LU1794554557.SGD","LU0456827905.SGD","LU0348825331.USD","LU0043850808.USD","LU0359201612.USD","02269","BK1610","LU0823426480.USD","LU1688375341.USD"],"gpt_icon":0},{"id":"2610520630","title":"Macquarie Upgrades ZTO Express (Cayman) to Outperform From Neutral, Adjusts Price Target to $26.60 From $18.40","url":"https://stock-news.laohu8.com/highlight/detail?id=2610520630","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610520630?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:28","pubTimestamp":1770640115,"startTime":"0","endTime":"0","summary":"ZTO Express (Cayman) (ZTO) has an average rating of buy and mean price target of $24.45, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02057","91347","MQG.AU","ZTO"],"gpt_icon":0},{"id":"2610680596","title":"Wuxi Biologics (Cayman) Stock Rises 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2610680596","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610680596?lang=en_us&edition=fundamental","pubTime":"2026-02-09 16:33","pubTimestamp":1770625980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. advanced 1.5% to 38.24 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.8% to 27027.16.This was the stock's third consecutive day of gains.Wuxi Biologics  Inc. closed 10% below its 52-week high of HK$42.60, which the company achieved Oct. 3.Trading volume totaled 21.6 million shares, compared to the 50-day average of 34.7 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423174.USD","LU0516423091.SGD","LU0348735423.USD","02269","LU0456846285.SGD","LU3063872942.SGD","BK1141","LU0516422440.USD","BK1576","LU0359201612.USD","LU0516422366.SGD","LU0417516902.SGD","LU1688375341.USD","SG9999002562.SGD","LU0320764599.SGD","LU1794554557.SGD","LU0181495838.USD","LU0359202008.SGD","LU0516422952.EUR","LU0417516738.SGD","91347","LU0327786744.USD","LU2039709279.SGD","LU0708995583.HKD","LU0819121731.USD","LU0823426308.USD","LU1242518857.USD","BK1521","LU0572944931.SGD","LU0588546209.SGD","LU1880383366.USD","LU1720050803.USD","LU0856984785.SGD","LU0039217434.USD","LU0456827905.SGD","LU0051755006.USD","LU0823426480.USD","LU0348825331.USD","LU0043850808.USD","SG9999002463.SGD","LU0052750758.USD","LU0307460666.USD","BK1589","LU0326950275.SGD","IE00B0JY6N72.USD","LU1242518931.SGD","LU0979878070.USD","LU0140636845.USD","BK1610"],"gpt_icon":0},{"id":"2609449534","title":"Qinqin Foodstuffs Group (Cayman) Company Limited's (HKG:1583) most bullish insider is Top Key Executive Ching Lau Hui, and their holdings value went up by 18% last week","url":"https://stock-news.laohu8.com/highlight/detail?id=2609449534","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609449534?lang=en_us&edition=fundamental","pubTime":"2026-02-06 07:07","pubTimestamp":1770332877,"startTime":"0","endTime":"0","summary":"Key Insights Qinqin Foodstuffs Group (Cayman)'s significant insider ownership suggests inherent interests in company's...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/5122000-choice2-main-header/1585186547117","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5122000-choice2-main-header/1585186547117"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/food-beverage-tobacco/hkg-1583/qinqin-foodstuffs-group-cayman-shares/news/qinqin-foodstuffs-group-cayman-company-limiteds-hkg1583-most","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/food-beverage-tobacco/hkg-1583/qinqin-foodstuffs-group-cayman-shares/news/qinqin-foodstuffs-group-cayman-company-limiteds-hkg1583-most","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1549","91347","BK1237","01583"],"gpt_icon":0},{"id":"2609585078","title":"Dingdong (Cayman) Ltd. Down Over 15%, on Pace for Largest Percent Decrease Since May 2024 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2609585078","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609585078?lang=en_us&edition=fundamental","pubTime":"2026-02-06 03:05","pubTimestamp":1770318300,"startTime":"0","endTime":"0","summary":"Dingdong  Ltd. Sponsored ADR Class A  is currently at $2.70, down $0.50 or 15.47%. --Would be lowest close since Jan. 20, 2026, when it closed at $2.69. --On pace for largest percent decrease since May 13, 2024, when it fell 15.74%. --Down 92.94% from its all-time closing high of $38.30 on June 30, 2021. --Down 18.03% from 52 weeks ago , when it closed at $3.30. --Up 61.98% from its 52-week closing low of $1.67 on Nov. 7, 2025. --Traded as low as $2.60; lowest intraday level since Jan. 20, 2026, when it hit $2.55. --Down 18.75% at today's intraday low; largest intraday percent decrease since May 13, 2024, when it fell as much as 21.3%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["91347","BK4551","91348","BK4539","BK4113","DDL"],"gpt_icon":0},{"id":"2609758325","title":"WuXi Biologics Alliances Deepen Role In Complex Autoimmune And Fusion Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2609758325","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609758325?lang=en_us&edition=fundamental","pubTime":"2026-02-06 00:36","pubTimestamp":1770309366,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) (SEHK:2269) announced new alliances with Vertex Pharmaceuticals and Sinorda Biomedicine for co-development and manufacturing of biologics targeting autoimmune diseases.\nThe company also expanded its agreement with HanchorBio to cover next generation fusion protein programs.\nTogether, these collaborations broaden WuXi Biologics' role as a global contract research, development and manufacturing partner across multiple therapeutic modalities.\n\nWuXi Biologics focuses on...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-alliances-deepen-role-in-complex-autoimmune-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-alliances-deepen-role-in-complex-autoimmune-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0256863811.USD","LU0326950275.SGD","LU0823416689.USD","IE00B4R5TH58.HKD","LU0052750758.USD","IE00BJJMRZ35.SGD","LU0456827905.SGD","SG9999002463.SGD","LU1559883803.SGD","LU0516423174.USD","IE0002270589.USD","IE00B0JY6N72.USD","LU1778281490.HKD","BK1610","LU1242518931.SGD","LU2362541513.USD","LU1069344957.HKD","IE00B19Z3B42.SGD","LU0516422366.SGD","LU0061475181.USD","LU1688375341.USD","LU2362540622.SGD","LU1720050803.USD","91347","BK4588","BK1589","LU1093756325.SGD","LU3063872942.SGD","LU0348825331.USD","VRTX","BK1576","02269","LU0823426480.USD","LU2362541273.HKD","SG9999002562.SGD","IE0009355771.USD","LU0079474960.USD","IE00BZ9MQY76.HKD","VERX","LU0039217434.USD","LU0109394709.USD","LU0417516902.SGD","LU0181495838.USD","LU0757428866.USD","IE00B19Z9Z06.USD","LU0819121731.USD","LU1242518857.USD","IE00B19Z3581.USD","LU1035775433.USD","LU1585245621.USD"],"gpt_icon":0},{"id":"2609379692","title":"Phaos Technology Holdings (Cayman) Limited Provides Response to Unusual Market Action","url":"https://stock-news.laohu8.com/highlight/detail?id=2609379692","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609379692?lang=en_us&edition=fundamental","pubTime":"2026-02-05 19:00","pubTimestamp":1770289200,"startTime":"0","endTime":"0","summary":"SINGAPORE, Feb.  05, 2026  (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), (“the Company”), an advanced microscopy solutions headquartered in Singapore, announce","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/05/3232769/0/en/Phaos-Technology-Holdings-Cayman-Limited-Provides-Response-to-Unusual-Market-Action.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["91347"],"gpt_icon":0},{"id":"2609099324","title":"Wuxi Biologics (Cayman) Stock Advances 2.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2609099324","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609099324?lang=en_us&edition=fundamental","pubTime":"2026-02-05 16:31","pubTimestamp":1770280260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rose 2.6% to 37.52 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 26885.24.Wuxi Biologics  Inc. closed 12% below its 52-week high of HK$42.60, which the company achieved Oct. 3.Trading volume totaled 28.1 million shares, compared to the 50-day average of 35.3 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU3063872942.SGD","LU1242518857.USD","LU0327786744.USD","LU2039709279.SGD","LU0417516902.SGD","LU0320764599.SGD","LU0051755006.USD","LU0572944931.SGD","LU1242518931.SGD","LU0516423174.USD","LU0856984785.SGD","SG9999002562.SGD","LU0039217434.USD","BK1521","LU0456846285.SGD","LU0359202008.SGD","LU1880383366.USD","LU0181495838.USD","LU0307460666.USD","LU0417516738.SGD","LU0516422952.EUR","LU0819121731.USD","LU0516422440.USD","LU0979878070.USD","IE00B0JY6N72.USD","LU1720050803.USD","LU0516422366.SGD","SG9999002463.SGD","BK1141","BK1576","LU0588546209.SGD","LU0326950275.SGD","91347","LU0052750758.USD","LU0516423091.SGD","LU0708995583.HKD","LU0823426308.USD","BK1589","LU0140636845.USD","LU0348735423.USD","LU1794554557.SGD","LU0456827905.SGD","LU0348825331.USD","LU0043850808.USD","LU0359201612.USD","02269","BK1610","LU0823426480.USD","LU1688375341.USD"],"gpt_icon":0},{"id":"2608368531","title":"Assessing WuXi Biologics (SEHK:2269) Valuation After New Autoimmune And Biologics Collaboration Wins","url":"https://stock-news.laohu8.com/highlight/detail?id=2608368531","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608368531?lang=en_us&edition=fundamental","pubTime":"2026-02-04 16:27","pubTimestamp":1770193646,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) (SEHK:2269) has drawn fresh attention after entering into a license and research service agreement with Vertex Pharmaceuticals for trispecific T cell engagers targeting B cell mediated autoimmune diseases.\nSee our latest analysis for WuXi Biologics (Cayman).\nThose fresh collaborations with Vertex, Sinorda and HanchorBio arrive as WuXi Biologics’ share price sits at HK$36.98, with a 1 month share price return of 13.64% and a 1 year total shareholder return of 87.91%...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/assessing-wuxi-biologics-sehk2269-valuation-after-new-autoim","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/assessing-wuxi-biologics-sehk2269-valuation-after-new-autoim","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1720050803.USD","LU0588546209.SGD","LU0417516738.SGD","LU1794554557.SGD","91347","LU0348735423.USD","BK1610","LU0456846285.SGD","LU0516423174.USD","LU1242518931.SGD","LU1688375341.USD","LU1880383366.USD","LU0327786744.USD","SG9999002463.SGD","SG9999002562.SGD","LU1242518857.USD","LU0348825331.USD","LU0140636845.USD","LU0181495838.USD","LU0039217434.USD","LU0043850808.USD","LU3063872942.SGD","BK1576","LU0320764599.SGD","02269","LU0456827905.SGD","LU0417516902.SGD","LU0516423091.SGD","LU0326950275.SGD","LU0359201612.USD","LU0979878070.USD","LU0516422366.SGD","LU0359202008.SGD","LU0051755006.USD","LU0819121731.USD","BK1521","LU0708995583.HKD","LU0307460666.USD","BK1589","LU2039709279.SGD","LU0516422952.EUR","LU0823426308.USD","LU0572944931.SGD","LU0856984785.SGD","LU0052750758.USD","IE00B0JY6N72.USD","LU0516422440.USD","LU0823426480.USD","BK1141"],"gpt_icon":0},{"id":"2608333709","title":"Returns On Capital Are Showing Encouraging Signs At Luyuan Group Holding (Cayman) (HKG:2451)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608333709","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608333709?lang=en_us&edition=fundamental","pubTime":"2026-02-04 07:07","pubTimestamp":1770160078,"startTime":"0","endTime":"0","summary":"If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/4022000-choice2-main-header/1585186789931","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4022000-choice2-main-header/1585186789931"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/automobiles/hkg-2451/luyuan-group-holding-cayman-shares/news/returns-on-capital-are-showing-encouraging-signs-at-luyuan-g","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/automobiles/hkg-2451/luyuan-group-holding-cayman-shares/news/returns-on-capital-are-showing-encouraging-signs-at-luyuan-g","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1111","02451","91347","EBIT"],"gpt_icon":0},{"id":"2608859923","title":"Wuxi Biologics (Cayman) Stock Slides 3.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2608859923","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608859923?lang=en_us&edition=fundamental","pubTime":"2026-02-02 16:32","pubTimestamp":1770021120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slipped 3.1% to 35.86 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 2.2% to 26775.57.This was the stock's third consecutive day of losses.Wuxi Biologics  Inc. closed 16% below its 52-week high of HK$42.60, which the company reached Oct. 3.Trading volume totaled 43.7 million shares, compared to the 50-day average of 35.3 million shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052750758.USD","LU0348825331.USD","LU0359201612.USD","SG9999002463.SGD","LU0708995583.HKD","BK1589","LU1794554557.SGD","LU0051755006.USD","02269","LU0140636845.USD","LU0039217434.USD","LU1242518857.USD","LU0348735423.USD","LU3063872942.SGD","LU0572944931.SGD","BK1610","91347","LU0417516738.SGD","LU0456846285.SGD","LU0327786744.USD","LU0588546209.SGD","BK1576","LU0819121731.USD","LU1242518931.SGD","LU0456827905.SGD","LU0043850808.USD","LU0516423091.SGD","LU0320764599.SGD","LU1688375341.USD","SG9999002562.SGD","LU0326950275.SGD","LU0516423174.USD","LU0516422440.USD","IE00B0JY6N72.USD","LU0823426308.USD","LU0979878070.USD","BK1521","LU1880383366.USD","LU0516422952.EUR","LU0856984785.SGD","LU2039709279.SGD","LU0181495838.USD","LU1720050803.USD","LU0359202008.SGD","LU0417516902.SGD","LU0516422366.SGD","LU0823426480.USD","BK1141","LU0307460666.USD"],"gpt_icon":0},{"id":"2607097756","title":"Wuxi Biologics (Cayman) Stock Sheds 2.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2607097756","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607097756?lang=en_us&edition=fundamental","pubTime":"2026-01-30 16:33","pubTimestamp":1769761980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. shed 2.4% to 37.00 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 2.1% to 27387.11.This was the stock's second consecutive day of losses.Wuxi Biologics  Inc. closed 13% short of its 52-week high of HK$42.60, which the company achieved Oct. 3.Trading volume totaled 25.4 million shares, compared to the 50-day average of 35.5 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU3063872942.SGD","LU0823426480.USD","LU0516423091.SGD","LU0417516902.SGD","91347","LU0516422440.USD","IE00B0JY6N72.USD","LU0181495838.USD","LU1688375341.USD","LU0823426308.USD","LU0856984785.SGD","LU0307460666.USD","LU1880383366.USD","LU0043850808.USD","LU0516422366.SGD","SG9999002463.SGD","LU0708995583.HKD","LU1794554557.SGD","LU0819121731.USD","LU1720050803.USD","LU0456846285.SGD","LU0052750758.USD","BK1576","LU0320764599.SGD","BK1610","LU0348825331.USD","LU0039217434.USD","BK1589","LU0516423174.USD","LU1242518931.SGD","SG9999002562.SGD","02269","LU0417516738.SGD","LU0456827905.SGD","LU0327786744.USD","LU0588546209.SGD","LU0572944931.SGD","BK1141","LU0979878070.USD","LU0359201612.USD","LU0359202008.SGD","LU0348735423.USD","LU0516422952.EUR","LU2039709279.SGD","LU1242518857.USD","BK1521","LU0140636845.USD","LU0051755006.USD","LU0326950275.SGD"],"gpt_icon":0},{"id":"2606570218","title":"Wuxi Biologics (Cayman) Stock Slides 2.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2606570218","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606570218?lang=en_us&edition=fundamental","pubTime":"2026-01-26 16:32","pubTimestamp":1769416320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. shed 2.8% to 38.22 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 26765.52.The stock's fall snapped a three-day winning streak.Wuxi Biologics  Inc. closed 10% short of its 52-week high of HK$42.60, which the company reached Oct. 3.Trading volume totaled 27.6 million shares, compared to the 50-day average of 36.0 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422952.EUR","SG9999002562.SGD","LU0417516738.SGD","LU0456846285.SGD","LU0516423091.SGD","LU0823426308.USD","LU1242518857.USD","02269","LU0417516902.SGD","LU1880383366.USD","LU2039709279.SGD","IE00B0JY6N72.USD","LU0588546209.SGD","LU0051755006.USD","LU0819121731.USD","LU0856984785.SGD","LU1794554557.SGD","LU0359201612.USD","LU0039217434.USD","LU0708995583.HKD","BK1521","LU0052750758.USD","BK1589","LU1688375341.USD","SG9999002463.SGD","LU1242518931.SGD","LU0516423174.USD","LU0140636845.USD","LU0572944931.SGD","BK1610","LU0359202008.SGD","BK1576","LU3063872942.SGD","BK1141","LU0326950275.SGD","LU0327786744.USD","LU0456827905.SGD","LU0320764599.SGD","LU0979878070.USD","LU0516422440.USD","LU0181495838.USD","LU0307460666.USD","91347","LU0348735423.USD","LU0823426480.USD","LU0043850808.USD","LU0516422366.SGD","LU1720050803.USD","LU0348825331.USD"],"gpt_icon":0},{"id":"2606637266","title":"A Look At ZTO Express (NYSE:ZTO) Valuation After Its 2026 Network Conference Growth Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2606637266","media":"Simply Wall St.","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606637266?lang=en_us&edition=fundamental","pubTime":"2026-01-26 02:19","pubTimestamp":1769365186,"startTime":"0","endTime":"0","summary":"ZTO Express (Cayman) (ZTO) used its 2026 National Network Conference to highlight 2025 parcel volumes of 38.52 billion, 13.3% above the prior year, and reaffirmed a plan focused on quality, safety, and efficiency.\nSee our latest analysis for ZTO Express (Cayman).\nAt a share price of $21.92, ZTO's 90 day share price return of 13.22% and 1 year total shareholder return of 21.42% sit against weaker 3 and 5 year total shareholder returns. This suggests momentum has picked up more recently than...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3211000-choice1-main-header/1585186856220","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3211000-choice1-main-header/1585186856220"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/transportation/nyse-zto/zto-express-cayman/news/a-look-at-zto-express-nysezto-valuation-after-its-2026-netwo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/transportation/nyse-zto/zto-express-cayman/news/a-look-at-zto-express-nysezto-valuation-after-its-2026-netwo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0348825331.USD","BK1151","02057","91347","BK1575","BK4131","BK1588","IE00BPRC5H50.USD","BK4526","BK4502","BK4535","ZTO","IE00B29SXG58.USD","BK4503","BK1541","NYSE","BK4558","LU0417516902.SGD","BK4505","IE00B543WZ88.USD","BK4585","BK1502","BK4588","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2605284045","title":"Capital Allocation Trends At Tenfu (Cayman) Holdings (HKG:6868) Aren't Ideal","url":"https://stock-news.laohu8.com/highlight/detail?id=2605284045","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605284045?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:56","pubTimestamp":1769208971,"startTime":"0","endTime":"0","summary":"What financial metrics can indicate to us that a company is maturing or even in decline? Businesses in decline often...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/5122000-choice2-main-header/1585186547117","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5122000-choice2-main-header/1585186547117"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/food-beverage-tobacco/hkg-6868/tenfu-cayman-holdings-shares/news/capital-allocation-trends-at-tenfu-cayman-holdings-hkg6868-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/food-beverage-tobacco/hkg-6868/tenfu-cayman-holdings-shares/news/capital-allocation-trends-at-tenfu-cayman-holdings-hkg6868-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1237","EBIT","91347","06868"],"gpt_icon":0},{"id":"2605740387","title":"New UK MHRA Certifications and PatroLab Platform Might Change The Case For Investing In WuXi Biologics (Cayman) (SEHK:2269)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605740387","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605740387?lang=en_us&edition=fundamental","pubTime":"2026-01-23 16:39","pubTimestamp":1769157579,"startTime":"0","endTime":"0","summary":"WuXi Biologics recently announced that its Wuxi Drug Product Facility 5 and Drug Product Packaging Center received UK MHRA GMP certifications for commercial ophthalmic biologic manufacturing, alongside the launch of its PatroLabTM digital twin platform for real-time bioprocess monitoring and control.\nTogether, these developments highlight WuXi Biologics’ growing role as a globally compliant manufacturer that is integrating advanced digital technologies to enhance biologics quality and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/new-uk-mhra-certifications-and-patrolab-platform-might-chang","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/new-uk-mhra-certifications-and-patrolab-platform-might-chang","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU3063872942.SGD","LU1242518857.USD","LU0327786744.USD","LU2039709279.SGD","LU0417516902.SGD","LU0320764599.SGD","LU0051755006.USD","LU0572944931.SGD","LU1242518931.SGD","LU0516423174.USD","LU0856984785.SGD","SG9999002562.SGD","LU0039217434.USD","BK1521","LU0456846285.SGD","LU0359202008.SGD","LU1880383366.USD","LU0181495838.USD","LU0307460666.USD","LU0417516738.SGD","LU0516422952.EUR","LU0819121731.USD","LU0516422440.USD","LU0979878070.USD","IE00B0JY6N72.USD","LU1720050803.USD","LU0516422366.SGD","SG9999002463.SGD","BK1141","BK1576","LU0588546209.SGD","LU0326950275.SGD","91347","LU0052750758.USD","LU0516423091.SGD","LU0708995583.HKD","LU0823426308.USD","BK1589","LU0140636845.USD","LU0348735423.USD","LU1794554557.SGD","LU0456827905.SGD","LU0348825331.USD","LU0043850808.USD","LU0359201612.USD","02269","BK1610","LU0823426480.USD","LU1688375341.USD"],"gpt_icon":0},{"id":"2605476550","title":"ZTO Express Shifts To Quality Led Growth After Volume Leadership Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2605476550","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605476550?lang=en_us&edition=fundamental","pubTime":"2026-01-23 14:52","pubTimestamp":1769151121,"startTime":"0","endTime":"0","summary":"ZTO Express (Cayman) set out a new quality led growth plan at its 2026 National Network Conference.\nThe company highlighted priorities around operational safety, service upgrades, and network optimization.\nThe update follows a decade of industry leadership and expansion in parcel and reverse logistics volumes.\n\nFor investors watching NYSE:ZTO, the new roadmap arrives with the stock at $22.32 and a 25.1% gain over the past year. Over a 3 year and 5 year span, returns of 16.3% and 24.8%...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/3211000-choice1-main-header/1585186856220","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3211000-choice1-main-header/1585186856220"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/transportation/nyse-zto/zto-express-cayman/news/zto-express-shifts-to-quality-led-growth-after-volume-leader","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/transportation/nyse-zto/zto-express-cayman/news/zto-express-shifts-to-quality-led-growth-after-volume-leader","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1151","IE00B29SXG58.USD","BK4502","IE00B543WZ88.USD","BK4558","BK1588","LU0417516902.SGD","BK1502","BK4588","LU0348825331.USD","02057","BK4131","BK4505","IE00B5MMRT66.SGD","BK4535","BK1575","BK4503","ZTO","91347","BK4585","IE00BPRC5H50.USD","BK4526","BK1541"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}